Lazard Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-47
Closed – – 2478
2024
Q4
$0 Sell
47
-21,840
-100% -$339K ﹤0.01% 2448
2024
Q3
$322K Buy
21,887
+10,790
+97% +$169K ﹤0.01% 1506
2024
Q2
$153K Buy
11,097
+5,861
+112% +$83.1K ﹤0.01% 1636
2024
Q1
$82K Sell
5,236
-16,046
-75% -$248K ﹤0.01% 1596
2023
Q4
$344K Buy
+21,282
New +$348K ﹤0.01% 1215

Other funds holding NEO

Lazard Asset Management's NEO Position: Q1 2025 in Review

Lazard Asset Management sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 47 shares.

Lazard Asset Management first reported a position in NEO in Q4 2023 and held it in 5 quarters. The position peaked at $344K in Q4 2023. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Lazard Asset Management reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 47 NeoGenomics shares in Q1 2025.
  • Lazard Asset Management first reported a position in NeoGenomics in Q4 2023 and held it in 5 quarters.
  • Lazard Asset Management's NeoGenomics position peaked at $344K in Q4 2023.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.